Kj. Turner et al., Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility, J ENDOCR, 164(2), 2000, pp. 225-238
The aim of the present study was to evaluate the effects of the administrat
ion of a potent non-steroidal aromatase inhibitor, anastrozole, on male rep
roductive function in adult rats. As anastrozole was to be administered via
the drinking water, a preliminary study was undertaken in female rats and
showed that this route of administration was effective in causing a major d
ecrease in uterine weight (P<0.02). In an initial study in male adult rats,
anastrozole (100 mg/l or 100 mg/l) was administered via the drinking water
for a period of 9 weeks. Treatment with either dose resulted in a signific
ant increase (similar to 10%) in testis weight and increase in plasma FSH c
oncentrations (P<0.01) throughout the 9 weeks. Mating was altered in both g
roups of anastrozole-treated rats, as they failed to produce copulatory plu
gs. Histological evaluation of the testes from anastrozole-treated rats rev
ealed that spermatogenesis was grossly normal. In a more detailed study, ad
ult rats were treated with 200 mg/l anastrozole via the drinking water for
periods ranging front 2 weeks to 1 year. Plasma FSH and testosterone concen
trations were increased significantly (P<0.001) during the first 19 weeks o
f treatment. However, LH concentrations were increased only at 19 weeks (P<
0.001) in anastrozole-treated rats, and this coincided with a further incre
ase in circulating and intratesticular testosterone concentrations (P<0.05)
. No consistent change in inhibin-B concentrations was observed during the
study. Suppression of plasma oestradiol concentrations could not be demonst
rated in anastrozole-treated animals, but oestradiol concentrations in test
icular interstitial fluid were reduced by 18% (P<0.01). Mating was again in
hibited by anastrozole treatment, but could be restored by s.c, injection o
f oestrogen, enabling demonstration that rats treated for 10 weeks or 9 mon
ths were still fertile. Testis weight was increased by 19% and 6% after tre
atment for 19 weeks and 1 year, respectively. Body weight was significantly
decreased (P<0.01) by 19 weeks of anastrozole treatment; after 1 year the
animals appeared to have less fat as indicated by a 27% decrease in the wei
ght of the gonadal fat pad. The majority of anastrozole-treated animals had
testes with normal spermatogenesis but, occasionally, seminiferous tubules
showed abnormal loss of germ cells or contained only Sertoli cells. Ten pe
rcent of anastrozole-treated animals had testes that appeared to contain on
ly Sertoli cells, and one rat had 'giant' testes in which the tubule lumens
were severely dilated. Morphometric analysis of the normal testes at 19 we
eks showed no difference in the number of Sertoli cells or germ cells, or t
he percentage volumes of the seminiferous epithelium, tubule lumens and int
erstitium between control and anastrozole-treated rats. On the basis of the
present findings, oestrogen appears to be involved in the regulation of FS
H secretion and testosterone production, and is also essential for normal m
ating behaviour in male rats. Furthermore, these data suggest that the brai
n and the hypothalamo-pituitary axis are considerably more susceptible than
is the testis to the effects of an aromatase inhibitor. Anastrozole treatm
ent has resulted in a model of brain oestrogen insufficiency.